Cargando…
Venous thrombosis epidemiology, pathophysiology, and anticoagulant therapies and trials in severe acute respiratory syndrome coronavirus 2 infection
OBJECTIVE: Infection with the severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) virus confers a risk of significant coagulopathy, with the resulting development of venous thromboembolism (VTE), potentially contributing to the morbidity and mortality. The purpose of the present review was...
Autores principales: | Obi, Andrea T., Barnes, Geoffrey D., Napolitano, Lena M., Henke, Peter K., Wakefield, Thomas W. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
by the Society for Vascular Surgery. Published by Elsevier Inc.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7834652/ https://www.ncbi.nlm.nih.gov/pubmed/32916371 http://dx.doi.org/10.1016/j.jvsv.2020.08.030 |
Ejemplares similares
-
Venous thrombosis, thromboembolism, biomarkers of inflammation, and coagulation in coronavirus disease 2019
por: Thondapu, Vikas, et al.
Publicado: (2021) -
Clinical and laboratory characteristics of patients with novel coronavirus disease-2019 infection and deep venous thrombosis
por: Motaganahalli, Raghu L., et al.
Publicado: (2021) -
Clinical characteristics of acute lower extremity deep venous thrombosis diagnosed by duplex in patients hospitalized for coronavirus disease 2019
por: Koleilat, Issam, et al.
Publicado: (2021) -
Deep vein thrombosis in hospitalized patients with coronavirus disease 2019
por: Chang, Heepeel, et al.
Publicado: (2021) -
Thrombosis at hospital presentation in patients with and without coronavirus disease 2019
por: Brosnahan, Shari B., et al.
Publicado: (2021)